S.Medical marijuana use is permitted in 36 states and recreational use is permitted in 17 states. Researchers looking to study the drug’s health effects have been limited to a single legal supplier of the drug, the University of Mississippi, since 1968. That is set to change soon, as the U.S. Drug Enforcement Administration (DEA) announced on Friday, May 14th that it had issued Memorandums of Agreements (MOAs) to hopeful growers setting out how the applicant and the DEA will work together to facilitate the manufacture, storage, packaging and distribution of marijuana under the new regulations. ”
“We were euphoric. This is a victory for scientific freedom. There is finally a chance to use real cannabis in our own studies and deliver genetically diverse cannabis to scientists across the country, ”said Sue Sisley, President and Principal Researcher, Scottsdale Research Institute (SRI) science.
According to scienceSome researchers like Sisley say that University of Mississippi marijuana is of poor quality while others see no problem with its quality but still welcome the prospect of additional suppliers. “Older people will not smoke. . . . They’ll have a brownie, a gummy bear. New manufacturers could give us these products, ”Igor Grant, director of the Center for Medical Cannabis Research at the University of California at San Diego, told the publication. “What is needed is more product and more variety.”
The DEA’s action was a long time coming. In 2016, the final year of President Barack Obama’s tenure, the agency announced that it would accept applications from emerging new marijuana growers for research purposes. But loud The Wall Street JournalDuring President Donald Trump’s tenure, officials such as then Attorney General Jeff Sessions rejected the change on the grounds that it might violate a United Nations drug trafficking treaty, and the application process was suspended. In 2019, the DEA announced plans to develop new regulations to regulate growth for scientific and medical purposes. At the end of last year, the new regulation was finally determined.
The DEA’s recent announcement did not specify how many MOAs had been shipped, but rather the number diary identified three organizations that received it, including SRI. “As these MOAs are completed, DEA expects to issue DEA registrations to these manufacturers. Each applicant will then be eligible to grow marijuana – up to their allotted quota – to support the more than 575 DEA-licensed researchers across the country, ”the agency said on Friday.
“This is a monumental step,” says George Hodgin, whose Biopharmaceutical Research Company received an MOA diary. “This kind of long-term government thinking will allow companies like us to open a nationwide legal cannabis market for products that have been tested and approved to help the public.”